Literature DB >> 6778551

Antipyrine clearance in psoriasis.

P H Chapman, B Keys, M D Rawlins, C Moss, S Shuster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6778551      PMCID: PMC1503795          DOI: 10.1136/bmj.282.6257.20

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Assessment of antipyrine kinetics by measurement in saliva.

Authors:  H S Fraser; J C Mucklow; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

2.  Generalised tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis.

Authors:  P H Chapman; P J Kersey; B Keys; S Shuster; M D Rawlins
Journal:  Br Med J       Date:  1980-11-15

3.  Activity of aryl hydrocarbon hydroxylase in psoriatic skin.

Authors:  P H Chapman; M D Rawlins; S Shuster
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

  3 in total
  5 in total

1.  Immunity and depression.

Authors:  A M Denman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

2.  Antipyrine clearance and metabolism in patients with psoriasis.

Authors:  K Kubota; T Ishizaki; K Chiba; A Takagi; A Nakagawa; K Nakamura
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

3.  Reduction of antipyrine clearance in psoriasis.

Authors:  J R Marsden; F M Williams; B Keys; M D Rawlins; S Shuster
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

4.  Polymorphic 4-hydroxylation of debrisoquine in chronic discoid psoriasis.

Authors:  P H Chapman; M D Rawlins; S Shuster; J R Idle; J C Ritchie; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Aryl hydrocarbon hydroxylase activity in cultured lymphocytes of psoriatic patients.

Authors:  N T Kärki; J Karvonen; O Pelkonen
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.